The impact of psychopharmacotherapy on disenrollment from office based opioid treatment with buprenorphine

Weinstein, Zoe; Cheng, Debbie M.; Quinn, Emily; Hui, David S.; Kim, Hyun‐Joong; Gryczynski, Gabriela; LaBelle, Colleen; Samet, Jeffrey H.

doi:10.1016/j.drugalcdep.2016.08.588

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous research has identified HCV infection as factor impeding long-term treatment retention (33). Engaging and retaining patients in treatment with MOUD decreases mortality and is associated with a more durable and safer recovery (34). Improved retention in the treatment group could be due to pre-existing clinical relationships based on trust, which may act as an antidote to the sequelae of stigma (33).…”

Section: Discussionmentioning

confidence: 99%

Integrated hepatitis C treatment is associated with improved retention and success in outpatient treatment for opioid use disorder at a private clinic

et al. 2022

View full text Add to dashboard Cite

BackgroundDirect acting antiretrovirals (DAA) are effective for individuals who are infected with chronic hepatitis C virus (HCV), yet many people go without access to these lifesaving treatments.Materials and methodsWe conducted a non-randomized study evaluating treatment data for patients in outpatient treatment for opioid use disorder (OUD) at a private clinic. Patients who were HCV-positive, had been in OUD treatment for at least 4 weeks, and engaged in integrated HCV treatment with DAA (co-located within their treatment for OUD) were compared to patients with HCV who only received OUD treatment. We evaluated HCV cure; OUD medication adherence, treatment utilization and retention; and illicit substance use for those engaged in treatment between 9/2016 and 1/2018.ResultsSeventy-four patients completed integrated HCV-OUD treatment with DAA, with 87.8% achieving cure. Of the 66 who completed treatment and were subsequently evaluated for sustained viral response 98.5% were cured. Patients who received integrated HCV and OUD treatment in our clinic, stayed in OUD treatment longer, demonstrated higher OUD medication adherence, and used less opioids or cocaine compared to HCV-infected patients (n = 572) being treated only for OUD.DiscussionWe have reported on a reproducible intervention that lends itself to outpatient OUD treatment. Analyses demonstrate the potential positive impact HCV treatment has on OUD recovery, including reduction in opioid and cocaine use and increased retention in careConclusionCo-locating HCV treatment with existing OUD treatment is feasible, effective, and demonstrates positive outcomes for the treatment of both conditions.

show abstract

Section: Discussionmentioning

confidence: 99%